Sensei Biotherapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Faeth Therapeutics,

03/11/2023 17:16

* Sensei Biotherapeutics Inc  SNSE.OQ   SNSE.O  is expected
to show no change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Sensei
Biotherapeutics
Inc is for a loss of 34 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $6​, above​ its last closing price
of $0.80. ​​​

This summary was machine generated November 3 at 17:16 GMT.  All
figures in US dollars  unless otherwise stated